Novel 13-n-octylberberine derivative with antineoplastic action

Abstract

The invention discloses a new synthesizing method of 13-n-octyl berberine (1) and 13-n-octyl palmatine (2) as berberine derivant and medical acceptable salt and liposome, which is characterized by the following: inhibiting the growth of cancer cell obviously through S180 transplanted tumour model test under lower dose condition; saving cost.

Description

technical field [0001] The present invention relates to the synthesis of new berberine derivatives, namely 13-n-octyl berberine (1) and 13-n-octyl palmatine (2), by using berberine and palmatine as raw materials respectively , and their pharmaceutically acceptable salts and liposomes have more significant antitumor activity, and their structural formulas are represented by the following formula: [0002] technical background [0003] Berberine (berberine), also known as berberine, is the main component extracted from the rhizomes of Coptis chinensis, Cortex Phellodendron, and Sankezhen, and belongs to the isoquinoline alkaloids. Berberine hydrochloride (also known as: berberine chloride, customarily called: berberine) is a quaternary ammonium compound, which has been used in China and India for the treatment of gastrointestinal diseases for more than 3,000 years (Lan Jin, Yang Shilin, Zheng Yuquan, et al; Research Progress of Coptidis Rhizome, Chinese Herbal Medicine, 20...

Images